David Siegel

Clinical/Research Interests

Title:

Chief of Medicine, Veterans Administration Northern California Health Care System, Professor and Vice Chair of Medicine, University of California, Davis

Specialty:

Internal Medicine, Infectious Diseases

Education:

Select Recent Publications:

Devaraj S, Siegel D, Jialal I. Post-JUPITER: statin therapy in metabolic syndrome and hypertension: value of CRP. Curr Atheroscler Rep 2011;13:31-42.

Siegel D, Swislocki A. The ACCORD study: the devil is in the details. Met Syndr Relat Disord 2011;9:81-84.

Devaraj S, Jialal G, Cook T, Siegel D, Jialal I. Low vitamin D levels in northern american adults with the metabolic syndrome. Horm Metab Res 2011;43:72-74.

Garcia EA, Lopez J, Meier J, Swislocki A, Siegel D. Resistant hypertension and undiagnosed primary hyperaldosteronism detected by use of a computerized database. J Clin Hypertens (Greenwich) 2011;13:487-91.

Devaraj S, Valleggi S, Siegel D, Jialal I. Role of c-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome. Curr Atheroscler Rep 2010;12:110-118.

Siegel D, Swislocki A. Treatment of hypertesnion in patients with the metabolic syndrome Met Syndr Relat Disord 2010;8:95-104.

Seeley A, Lopez J, Meier J, Swislocki A, Siegel D. The effect of body mass index on fasting blood glucose and development of diabetes mellitus after initiation of extended release niacin. Met Syndr Relat Disord 2009;8:79-84.

Swislocki A, Noth RH, Volpp B, Meier J, Siegel D. Computer confirmation of improved blood pressure control in diabetic patients. Preventive Cardiol 2009;12:149-154.

Kelley DS, Siegel D, et al. Docosahexaenoic acid supplementation decreases serum C-reactive protein and other markers of inflammation in hypertriglyceridemic men. J Nutr 2009;139:495-501.

Singh U, Deveraj S, Jialal I, Siegel D. Comparison Effect of Atorvastatin (10 mg versus 80 mg) on Biomarkers of Inflammation and Oxidative Stress in Subjects with the Metabolic Syndrome. Am J Cardiol 2008;102:321-325.